S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
NYSE:VEEV

Veeva Systems (VEEV) Stock Price, News & Analysis

$223.90
+2.26 (+1.02%)
(As of 02/26/2024 ET)
Today's Range
$221.75
$225.37
50-Day Range
$182.99
$223.90
52-Week Range
$160.21
$225.49
Volume
790,632 shs
Average Volume
936,693 shs
Market Capitalization
$36.05 billion
P/E Ratio
64.34
Dividend Yield
N/A
Price Target
$219.77

Veeva Systems MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.64 Rating Score
Upside/​Downside
1.8% Downside
$219.77 Price Target
Short Interest
Healthy
1.32% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.79
Upright™ Environmental Score
News Sentiment
0.86mentions of Veeva Systems in the last 14 days
Based on 22 Articles This Week
Insider Trading
Selling Shares
$7.52 M Sold Last Quarter
Proj. Earnings Growth
21.48%
From $2.84 to $3.45 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.76 out of 5 stars

Computer And Technology Sector

43rd out of 584 stocks

Prepackaged Software Industry

10th out of 196 stocks


VEEV stock logo

About Veeva Systems Stock (NYSE:VEEV)

Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and data solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. The company also provides Veeva Development Cloud, a suite of applications for the clinical, regulatory, quality, and safety functions, including Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality; Veeva QualityOne, a quality and document management, and training solution; Veeva RegulatoryOne, a solution that helps companies to manage regulatory submission content; and Veeva Claims addresses the end-to-end product and marketing claims management process. In addition, it offers professional and support services, including implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; data migration and systems integrations technical consulting services; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

VEEV Stock Price History

VEEV Stock News Headlines

Veeva Systems (NYSE:VEEV) Price Target Raised to $240.00
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Beyond Big Tech: 3 Industries to Invest In AI-Fueled Gains
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Veeva Systems (VEEV) Set to Announce Earnings on Thursday
Reasons to Add Veeva Systems (VEEV) to Your Portfolio Now
VEEV May 2024 230.000 call
VEEV Mar 2024 145.000 put
VEEV Jan 2026 290.000 put
VEEV Jul 2024 210.000 call
VEEV Jun 2024 100.000 call
2 Magnificent Growth Stocks to Buy With $500
Veeva Systems Inc Class A (VEEV)
See More Headlines
Receive VEEV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Veeva Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
12/06/2023
Today
2/26/2024
Next Earnings (Confirmed)
2/29/2024
Fiscal Year End
1/31/2025

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Employees
6,744
Year Founded
2007

Price Target and Rating

Average Stock Price Target
$219.77
High Stock Price Target
$265.00
Low Stock Price Target
$160.00
Potential Upside/Downside
-2.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.64
Research Coverage
22 Analysts

Profitability

Net Income
$487.71 million
Pretax Margin
23.55%

Debt

Sales & Book Value

Annual Sales
$2.16 billion
Cash Flow
$2.97 per share
Book Value
$23.48 per share

Miscellaneous

Free Float
143,336,000
Market Cap
$36.05 billion
Optionable
Optionable
Beta
0.74

Social Links

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Should I Buy Veeva Systems Stock? VEEV Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Veeva Systems was last updated on Tuesday, February 20, 2024 at 10:22 PM.

Pros

Here are some ways that investors could benefit from investing in Veeva Systems Inc.:

  • Veeva Systems Inc. provides cloud-based software tailored for the life sciences industry, offering solutions like Veeva Commercial Cloud and Veeva Development Cloud, catering to various functions within pharmaceutical and biotechnology companies.
  • Recent financial performance indicates positive growth, with the company reporting $1.34 EPS for the quarter, surpassing analysts' estimates and showcasing a revenue increase of 11.6% compared to the same period last year.
  • Veeva Systems Inc. has a strong market capitalization of $33.36 billion, reflecting investor confidence in the company's potential for growth and stability.
  • The company's stock price has shown resilience, trading at $207.15 with a 12-month high of $225.49, indicating a positive trend in the market valuation of Veeva Systems Inc.
  • Veeva Systems Inc. offers a range of professional and support services, including implementation planning, project management, and ongoing managed services, enhancing the overall customer experience and potentially attracting more clients.

Cons

Investors should be bearish about investing in Veeva Systems Inc. for these reasons:

  • Despite positive financial indicators, Veeva Systems Inc. operates in a competitive market, facing challenges from other software providers targeting the life sciences industry, which could impact the company's market share and growth potential.














VEEV Stock Analysis - Frequently Asked Questions

Should I buy or sell Veeva Systems stock right now?

22 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Veeva Systems in the last year. There are currently 1 sell rating, 6 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" VEEV shares.
View VEEV analyst ratings
or view top-rated stocks.

What is Veeva Systems' stock price target for 2024?

22 Wall Street analysts have issued 12 month target prices for Veeva Systems' stock. Their VEEV share price targets range from $160.00 to $265.00. On average, they expect the company's share price to reach $219.77 in the next year. This suggests that the stock has a possible downside of 1.8%.
View analysts price targets for VEEV
or view top-rated stocks among Wall Street analysts.

How have VEEV shares performed in 2024?

Veeva Systems' stock was trading at $192.52 at the beginning of the year. Since then, VEEV stock has increased by 16.3% and is now trading at $223.8950.
View the best growth stocks for 2024 here
.

When is Veeva Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 29th 2024.
View our VEEV earnings forecast
.

How can I listen to Veeva Systems' earnings call?

Veeva Systems will be holding an earnings conference call on Thursday, February 29th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Veeva Systems' earnings last quarter?

Veeva Systems Inc. (NYSE:VEEV) posted its quarterly earnings data on Wednesday, December, 6th. The technology company reported $1.34 EPS for the quarter, beating the consensus estimate of $1.29 by $0.05. The technology company had revenue of $616.51 million for the quarter, compared to analysts' expectations of $615.98 million. Veeva Systems had a trailing twelve-month return on equity of 10.91% and a net margin of 24.68%. The company's revenue for the quarter was up 11.6% compared to the same quarter last year. During the same period in the previous year, the business earned $0.69 earnings per share.

What guidance has Veeva Systems issued on next quarter's earnings?

Veeva Systems updated its FY 2025 earnings guidance on Friday, December, 29th. The company provided EPS guidance of for the period. The company issued revenue guidance of $2.8 billion-, compared to the consensus revenue estimate of $2.7 billion.

What is Peter Gassner's approval rating as Veeva Systems' CEO?

202 employees have rated Veeva Systems Chief Executive Officer Peter Gassner on Glassdoor.com. Peter Gassner has an approval rating of 82% among the company's employees.

What other stocks do shareholders of Veeva Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Veeva Systems investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), PayPal (PYPL), Shopify (SHOP), Walt Disney (DIS), Adobe (ADBE), Netflix (NFLX), Trade Desk (TTD) and Block (SQ).

Who are Veeva Systems' major shareholders?

Veeva Systems' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (8.17%), Artisan Partners Limited Partnership (4.09%), Price T Rowe Associates Inc. MD (3.61%), Massachusetts Financial Services Co. MA (1.35%), Van ECK Associates Corp (1.10%) and Nuveen Asset Management LLC (1.07%). Insiders that own company stock include Alan Mateo, Brent R Bowman, Eleni Nitsa Zuppas, Frederic Lequient, Jonathan Faddis, Joseph Christopher Hays, Mary Lynne Hedley, Matthew J Wallach, Matthew J Wallach, Michele O'connor, Paul Edward Chamberlain, Paul J Sekhri, Peter P Gassner, Ronald E F Codd, Steven L Fasman, Thomas D Schwenger and Timothy S Cabral.
View institutional ownership trends
.

How do I buy shares of Veeva Systems?

Shares of VEEV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Veeva Systems have any subsidiaries?
The following companies are subsidiares of Veeva Systems: AdvantageMS, Learnaboutgmp, Physicians World, Selligy, Veeva Crossix, Veeva RTSM, Veracity Logic, and Zinc Ahead Ltd.
Read More
This page (NYSE:VEEV) was last updated on 2/27/2024 by MarketBeat.com Staff